| PDF Reprint Files |
1) J. Inherited Metabolic
Disease, 2010, 33 (3) 195-210: Metabolic acetate therapy improves
phenotype in the tremor rat model of Canavan disease.
PDF
2) PNAS 2005, 102 (14) 5221-5226:
Defective N-acetylaspartate catabolism reduces brain acetate levels and
myelin lipid synthesis in Canavan's disease.
PDF
3) Progress in Neurobiology 2007,
81 (2) 89-131:
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology.
PDF
4) (2006)
Expression of N-acetylaspartate and N-acetylaspartylglutamate
in the nervous system, in N-Acetylaspartate: A Unique Neuronal
Molecule in the Central Nervous System, (Moffett J. R., Tieman S.
B., Weinberger D. R., Coyle J. T. and Namboodiri M. A., eds), Vol. 576,
pp. 7-26. Springer Science + Business Media, New York, NY.
PDF
5)
Moffett J. R., Namboodiri M.
A., Cangro C. B. and Neale J. H. (1991) Immunohistochemical localization
of N-acetylaspartate in rat brain. Neuroreport 2, 131-134.
PDF
|